Clinical Trial Update: Gallium-68 Labeled Pentixafor PET/CT in Adrenal Masses [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating Gallium-68 labeled Pentixafor PET/CT for adrenal masses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Mass

Drugs mentioned

• Gallium-68 labeled Pentixafor (pentixafor)
• Pentixafor (pentixafor)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Adrenal Mass | Phase 2, Phase 3 | Status: UNKNOWN